PRISM MarketView

Cybin Sets Stage for Phase 3 Trials for Major Depressive Disorder After Successful FDA Meeting

New York, August 16, 2024 - PRISM MarketView - The PRISM Psychedelics Index company Cybin Inc. (CYBN), a clinical-stage neuropsychiatry company, recently held a Type B Initial Breakthrough Therapy Meeting with the FDA in Washington, D.C. The company is on track to initia...

16 August 2024

Turtle Beach (HEAR) Continues to Ride the Gaming Wave As Shares Are Up 45% YTD

New York, August 16, 2024 - PRISM MarketView - The PRISM Consumer Products Index company Turtle Beach Corp (HEAR) is known for its audio technology as it markets gaming headset solutions. Since the start of the year, shares have seen a nice appreciation upwards around 45...

16 August 2024

Brands (TLRY) Brews Up Craft Beer Empire with Molson Coors Acquisition

New York, August 16, 2024 - PRISM MarketView - Shares of Tilray Brands (Nasdaq: TLRY) gained momentum following the announcement of its acquisition of four craft breweries from Molson Coors Beverage Company in an all-stock deal. This strategic move reinforces Tilray’s gr...

16 August 2024

AI Datacenter Stock Moves: TSS Inc. (TSSI) Reports Solid Q2 Growth as Shares Rise 25%

New York, August 15, 2024 - PRISM MarketView - TSS Inc. (TSSI) the data center services company that integrates AI and other high-performance computing infrastructure and software, reported Q2 results that posted 345% growth in net income ($1.4M from $0.3M in the prior y...

15 August 2024

Cingulate (CING) Shares Skyrocket Over 150% on European ADHD Patent Announcement

New York, August 15, 2024 - PRISM MarketView - PRISM Mental Health Index leader Cingulate (CING) saw shares rise over 150% on its recent news regarding the issuance of a European patent for its leading asset, CTx-1301 (dexmethylphenidate), designed for the treatment of A...

15 August 2024

Evolv (EVLV) Leads PRISM NextGen Tech and AI Index After Recent Security Patent Approval

New York, August 15, 2024 - PRISM MarketView - Recently, Evolv Technology (EVLV), a pioneering company in AI-based security screening, was granted a significant patent by the United States Patent and Trademark Office (USPTO) for its innovative technology used in its flag...

15 August 2024

Biopharma Mover: OS Therapies (OSTX) Announces Q2 Earnings

New York, August 15, 2024 - PRISM MarketView - Today the clinical-stage biopharmaceutical company OS Therapies (OSTX) announced Q2 earnings after its recent successful IPO that raised $6.4M on July 31, 2024. After IPO and preferred shares and debt conversion share issuan...

15 August 2024

NeuroBo Pharmaceuticals Leads PRISM Biotech Index with Q2 Cardiometabolic Milestones and $70M Funding Boost

New York, August 14, 2024 - PRISM MarketView - NeuroBo Pharmaceuticals (NRBO) leads the PRISM Biotech Index intraday after a strong Q2 2024 update. The company secured up to $70 million in financing, with $20 million upfront, to fund key milestones through Q2 2025. Highl...

14 August 2024

SKYX Raises Ceiling on Q2 Sales Reporting Record Revenues of $21.4M as it Penetrates US and Canadian Markets

New York, August 13, 2024 - PRISM MarketView - The smart platform technology and lighting company, SKYX Platforms Corp (SKYX) announced its second quarter earnings that generated a record $21.4M in revenues compared to the same period last year of $15M. Additionally, its...

13 August 2024

BioStem (BSEM) Reports Record Second Quarter Revenue of $74.5M with $116.4M Generated for the First Half of 2024

New York, August 13, 2024 - PRISM MarketView - Advanced wound care technology company BioStem Technologies (BSEM) announced its second quarter financials and achieved a second consecutive record quarter for the company. BioStem reported $74.5M in revenue for the second q...

13 August 2024